Your browser doesn't support javascript.
loading
Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou, Xiaofeng; Li, Yajie; Wang, Weilong; Wang, Sujie; Hou, Jinghan; Zhang, Aijia; Lv, Benjie; Gao, Can; Yan, Ziyi; Pang, Dan; Lu, Kui; Ahmad, Nor Hazwani; Wang, Lidong; Zhu, Jian; Zhang, Lichen; Zhuang, Ting; Li, Xiumin.
Afiliação
  • Zhou X; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Li Y; Henan Key Laboratory of immunology and targeted therapy, School of Laboratory Medicine, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Xinxiang, 453003, Henan Province, P.R. China.
  • Wang W; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Wang S; Department of Gastroenterology, the Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Hou J; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Zhang A; Department of Gastroenterology, the Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Lv B; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Gao C; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Yan Z; Department of Gastroenterology, the Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Pang D; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Lu K; Department of Gastroenterology, the Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Ahmad NH; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Wang L; Department of Gastroenterology, the Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Zhu J; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Zhang L; Department of Gastroenterology, the Third Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Zhuang T; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
  • Li X; Xinxiang Key Laboratory for Molecular Therapy of Cancer, Xinxiang Medical University, Xinxiang 453003, Henan Province, P.R. China.
Theranostics ; 10(21): 9443-9457, 2020.
Article em En | MEDLINE | ID: mdl-32863938
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Transdução de Sinais / Proteínas Serina-Treonina Quinases / Ubiquitina-Proteína Ligases / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Transdução de Sinais / Proteínas Serina-Treonina Quinases / Ubiquitina-Proteína Ligases / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article